Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease
Alex E. Roher(Barrow Neurological Institute), Mark R. Emmerling, James M. Tuohy(Banner Sun Health Research Institute), Yu‐Min Kuo(National Yang Ming Chiao Tung University), Amina S. Woods(Johns Hopkins University), W. Blaine Stine(Emory University), Lanny J. Haverkamp(Baylor College of Medicine), Grant A. Krafft(Northwestern University), Michael O. Chaney(Eli Lilly (United States)), Barry S. Bonnell(Arizona State University), Robert J. Cotter(Shirley Ryan AbilityLab), Scott D. Webster(Banner Sun Health Research Institute)
Cited by 507
Related Papers
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
|Journal of Biological Chemistry|1993|799
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.
|Proceedings of the National Academy of Sciences|1993|742
Cerebral Amyloid Angiopathy
|American Journal Of Pathology|1998|682